Evidence map›Paper›PMID 37234634›Full record

ArticleHeliyon2023

MiR-21 alleviates renal tubular epithelial cells injury induced by ischemia by targeting TLR4.

Xiu-Juan Liu, Jin-Lei Lv, Xin Zou, Yan-Yan Yu, Hong-Xia Zhou, Yu Wu, Yan-Qiu Geng, Cai-Hua Lie

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiu-Juan LiuDivision of Nephrology, The 908 Hospital of Joint Logistics Support Force, Nanchang, Jiangxi, 330000, China.
Jin-Lei LvDepartment of Nephrology, The First Affiliated Hospital of Nanchang University, Institute of Molecular Immunology of Kidney Disease of Nanchang University, Nanchang, Jiangxi, 330006, China.
Xin ZouDivision of Nephrology, The 908 Hospital of Joint Logistics Support Force, Nanchang, Jiangxi, 330000, China.
Yan-Yan YuDivision of Nephrology, The 908 Hospital of Joint Logistics Support Force, Nanchang, Jiangxi, 330000, China.
Hong-Xia ZhouDivision of Nephrology, The 908 Hospital of Joint Logistics Support Force, Nanchang, Jiangxi, 330000, China.
Yu WuDivision of Nephrology, The 908 Hospital of Joint Logistics Support Force, Nanchang, Jiangxi, 330000, China.
Yan-Qiu GengDivision of Nephrology, Third Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
Cai-Hua LieDivision of Nephrology, General Hospital of Xinjiang Military Region, Urumqi, Xinjiang, 830000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal ischemia is the initial stage of kidney damage, leading to mitochondrial metabolism disorders and cell necrosis. In this study, we aimed to investigate the biological functions and potential mechanisms of miR-21 in protecting renal tubular epithelial cells from oxidative stress and apoptosis following oxygen glucose deprivation (OGD). Following an OGD injury, miR-21 levels increased in HK-2 renal tubular epithelial cells. Overexpression of miR-21 decreased the protein expressions of cleaved caspase-3, BAX, P53, cell apoptosis and increased Bcl-2 expression in HK-2 cells with OGD injury.

Indexed as

AKTHIF-1αIschemiamiR-21RenalTLR4

Identifiers

PMID37234634
PMCPMC10205595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.